• Home >
  • Publications >
  • Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial

Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial

12 Jan 2024Nature Cancer

DOI : 10.1038/s43018-023-00709-6

Authors

Stephen J. Bagley, Zev A. Binder, Lamia Lamrani, Eliana Marinari, Arati S. Desai, MacLean P. Nasrallah, Eileen Maloney, Steven Brem, Robert A. Lustig, Goldie Kurtz, Michelle Alonso-Basanta, Pierre-Emmanuel Bonté, Christel Goudot, Wilfrid Richer, Eliane Piaggio, Shawn Kothari, Lea Guyonnet, Coralie L. Guerin, Joshua J. Waterfall, Suyash Mohan, Wei-Ting Hwang, Oliver Y. Tang, Meghan Logun, Meghna Bhattacharyya, Kelly Markowitz, Devora Delman, Amy Marshall, E. John Wherry, Sebastian Amigorena, Gregory L. Beatty, Jennifer L. Brogdon, Elizabeth Hexner, Denis Migliorini, Cecile Alanio, Donald M. O’Rourke

Members

ELIANE PIAGGIO

Directeur de recherche Inserm

SEBASTIAN AMIGORENA

Directeur de recherche CNRS

WILFRID RICHER

Ingénieur de recherche

CHRISTEL GOUDOT

Ingénieur de recherche

JOSHUA WATERFALL

Chargé de recherche Inserm
Default

LAMIA LAMRANI

Ingénieur de recherche